PROF Profound Medical Corporation Profit After Tax

Current liquidity for Profound Medical Corp. (PROF) remains within normal limits, however, expanding the distribution network requires expenditures that exceed cash inflows, leading to a gradual reduction in reserves. This metric stands at -0.03. The business relies on the supply and service of ultrasound robots for prostate therapy, generating profit from the sale of the systems themselves and ancillary consumables. The historical price action of the shares is presented below.

This indicator captures the daily inflow of actual cash, eliminating the lags associated with quarterly reporting. By analyzing the dynamics of the company's financial results, an investor can determine the objective stability of the cash flow. The calculation is based on daily corporate earnings, reflecting actual operating returns. This is critical for Profound Medical Corp. (PROF), as the implementation of ablation systems creates a long-term dependence of clinics on high-margin consumables. Such sales inertia ensures the stability of this metric.